---
document_datetime: 2025-08-13 15:23:36
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/instanyl-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: instanyl-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.5427688
conversion_datetime: 2025-12-28 12:11:18.753623
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Instanyl

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | Notification acc.Article61(3)-Accepted | 12/08/2025                          |                                          | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000291557                        | Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                      |            |     |                        |                                                                                                                                                     |
|-----------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IA / EMA/VR/0000286216   | B.III.1.aEuropeanPharmacopoeial CertificateofSuitabilitytotherelevantPh. Eur. Monograph - B.III.1.a.2 Updated certificate from an already approved manufacturer-Accepted                                                                                                                                                                                                  | 15/07/2025 | N/A |                        |                                                                                                                                                     |
| Variation typeIA_IN / EMA/VR/0000272889 | C.1.3Change(s)in theSummary of Product Characteristics,Labelling orPackageLeaflet of humanmedicinalproducts intended to implement the outcome of a procedure concerningPSURorPASS,ortheoutcome of the assessment done by the competent authority under Articles 45 or 46 of Regulation1901/2006-C.1.3.a Implementationofwordingagreedbythe competent authority - Accepted | 21/05/2025 |     | SmPC, Labelling and PL | Toupdatesection2ofthepackageleafletto implement the wording agreed by the EMA following theCMDhpositionforPSUSAforfentanyl (PSUSA/00001370/202404). |